Chemours Faces Investor Suit Over Alleged Exec Misconduct

By Emilie Ruscoe

Chemical company The Chemours Co. and four of its current and former executives face claims they hurt investors by manipulating a certain financial metric so the executives might receive greater compensation under the company's incentive plans.

 Complaint attached | Read full article » | Save to favorites »